‌

Arnatar

Arnatar Therapeutics Inc. is a San Diego-based biotechnology company founded in 2021 by Dr. Xuehai Liang and Dr. Yanfeng Wang. The company specializes in developing RNA-based therapies using its proprietary DARGER™ platform, which combines gene silencing with the ability to upregulate protein expression.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

RNA-based and RNA-targeted therapeutics

Location

B2X

CEO

Founder

Number of Employees (Ranges)

11 – 50

Email Address

info@arnatar.com

Phone Number

+18587577299

Investors

Jifeng Ventures

Zhuhai Huajin Capital

Eight Roads Ventures

Transfar Capital

3E Bioventures Capital (3E)

New Alliance Capital

F-Prime Capital Partners

Total Funding Amount (USD)

52,000,000

Latest Funding Round Date

August 25, 2025

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

52,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Arnatar

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.